Pfizer, BioNTech seek full FDA approval of COVID-19 vaccine

Pfizer and BioNTech on Friday said that they have begun their request for the Food and Drug Administration (FDA) to give full approval of its COVID-19 vaccine after having emergency use authorization for almost five months.

The companies announced they started their Biologics License Application (BLA) for the FDA to grant full authorization to give their vaccine to those 16 and older.